Cargando…
Timely Resolution of SARS-CoV-2-Related Multi-System Inflammatory Syndrome in Children
Background: Multisystem inflammatory syndrome in children (MIS-C) is a severe, postinfectious manifestation of coronavirus disease 2019 (COVID-19) in the pediatric population. The disease is manifested by hyperinflammation and can result in cardiac dysfunction, coronary changes, and end-organ damage...
Autores principales: | Reiff, Daniel D., Cron, Randy Q. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866445/ https://www.ncbi.nlm.nih.gov/pubmed/36680134 http://dx.doi.org/10.3390/v15010094 |
Ejemplares similares
-
Who Would Have Predicted Multisystem Inflammatory Syndrome in Children?
por: Reiff, Daniel D., et al.
Publicado: (2022) -
Performance of Cytokine Storm Syndrome Scoring Systems in Pediatric COVID‐19 and Multisystem Inflammatory Syndrome in Children
por: Reiff, Daniel D., et al.
Publicado: (2021) -
Host genetics of pediatric SARS-CoV-2 COVID-19 and multisystem inflammatory syndrome in children
por: Schulert, Grant S., et al.
Publicado: (2021) -
Cytokine Storm Syndrome Triggered by Extracorporeal Membrane Oxygenation in Pediatric Patients
por: Reiff, Daniel D., et al.
Publicado: (2023) -
Multisystem Inflammatory Syndrome in Children Related to SARS-CoV-2
por: Esposito, Susanna, et al.
Publicado: (2021)